JP Morgan strengthens core business, appoints new leader to lead development of technology and healthcare investment banking.

JPMorgan Chase (JPM.US) is restructuring its senior management team in its technology and healthcare investment banking business, promoting new leaders in these two key areas. According to an internal memo seen by Bloomberg News, the New York-based bank has appointed Pankaj Goel, Madhu Namburi, and Drago Rajkovic as global co-heads of technology investment banking, while Mike Gaito will serve as global head of healthcare. This personnel change highlights JPMorgan Chase - the largest bank in the United States - commitment to maintaining the vitality and competitiveness of its senior talent pool in the historically active sectors of healthcare and technology. In the memo, global co-heads of the bank Doug Petno and Filippo Gori stated, "These four new leaders bring extensive experience within the company and have been instrumental in driving growth in our investment banking business. Our clients and colleagues will benefit greatly from their extensive networks, strategic insights, and market expertise." All four newly appointed chairs will report directly to Petno and Gori. Goel previously served as co-head of technology investment banking for North America, Namburi was formerly global head of technology, and Rajkovic recently served as vice chairman. Gaito previously held the position of global head of healthcare investment banking. In another memo, JPMorgan Chase announced that Ben Carpenter and Jeremy Meilman have been appointed as global co-heads of healthcare investment banking, while Chris Grose and Greg Mendelson have been appointed as global co-heads of technology investment banking. They will report to global co-heads of investment banking Jay Horine and Dorothee Blessing. Carpenter will continue to serve as co-head of North America M&A business. A representative from JPMorgan Chase has confirmed the authenticity of these memos.